Name: Name:2-(4-Bromophenyl)imidazo[1,2-a]pyridine
Brand: AABLOCKS
SKU: AA00BYKT
Rating: 90 (10 reviews)

Technical Information

Catalog Number: AA00BYKT

Chemical Name: 2-(4-Bromophenyl)imidazo[1,2-a]pyridine

CAS Number: 34658-66-7

Molecular Formula: C13H9BrN2

Molecular Weight: 273.1280

MDL Number: MFCD00218250

SMILES: Brc1ccc(cc1)c1nc2n(c1)cccc2

Properties

BP: 216-220 °C at 760 mmHg

Form: Solid

MP: 216-220 °C

Storage: Keep in dry area;Room Temperature;

Complexity: 238

Covalently-Bonded Unit Count: 1

Defined Atom Stereocenter Count: 0

Defined Bond Stereocenter Count: 0

Formal Charge: 0

Heavy Atom Count: 16

Hydrogen Bond Acceptor Count: 1

Hydrogen Bond Donor Count: 0

Isotope Atom Count: 0

Rotatable Bond Count: 1

Undefined Atom Stereocenter Count: 0

Undefined Bond Stereocenter Count: 0

XLogP3: 4.1

Downstream Synthesis Route

504-29-0

99-73-0

34658-66-7

[1]AngewandteChemie-InternationalEdition,2015,vol.54,p.10313-10316 Angew.Chem.,2015,vol.127,p.10452-10456,5

[2]SyntheticCommunications,2005,vol.35,p.901-906

[3]Patent:EP2597094,2013,A1.Locationinpatent:Paragraph0089-0090

[4]JournaloftheIranianChemicalSociety,2015,vol.12,p.1369-1380

[5]Patent:EP2524913,2012,A1.Locationinpatent:Page/Pagecolumn33

[6]Patent:US2012/319099,2012,A1.Locationinpatent:Page/Pagecolumn34

[7]JournalofHeterocyclicChemistry,2020,vol.57,p.2279-2287

[8]Patent:US2008/125593,2008,A1.Locationinpatent:Page/Pagecolumn11-12

[9]Patent:EP1925618,2008,A1.Locationinpatent:Page/Pagecolumn15-16

[10]Patent:KR2016/39743,2016,A.Locationinpatent:Paragraph0418-0420

[11]Patent:EP2067778,2009,A1.Locationinpatent:Page/Pagecolumn199;200

[12]BioorganicandMedicinalChemistryLetters,2018,vol.28,p.2861-2864

[13]JournalofChemicalResearch-PartS,2003,p.614-615

[14]BulletinoftheChemicalSocietyofJapan,1999,vol.72,p.1327-1334

[15]Patent:EP2292601,2011,A1.Locationinpatent:Page/Pagecolumn19

[16]TetrahedronLetters,2017,vol.58,p.2771-2773

[17]RecueildesTravauxChimiquesdesPays-Bas,1949,vol.68,p.441,458

[18]JournalofHeterocyclicChemistry,1988,vol.25,p.129-137

[19]BioorganicandMedicinalChemistry,1998,vol.6,p.181-187

[20]TetrahedronLetters,2001,vol.42,p.3077-3080

[21]Patent:WO2007/34278,2007,A2.Locationinpatent:Page/Pagecolumn56

[22]Patent:US2012/267615,2012,A1.Locationinpatent:Page/Pagecolumn51

[23]Synlett,2012,vol.23,p.2609-2614,6

[24]JournalofHeterocyclicChemistry,2015,vol.52,p.641-646

[25]ChemicalBiologyandDrugDesign,2015,vol.86,p.849-856

[26]OrganicLetters,2015,vol.17,p.5208-5211

[27]ResearchonChemicalIntermediates,2016,vol.42,p.1989-1998

[28]GreenChemistry,2016,vol.18,p.1455-1458

[29]EuropeanJournalofOrganicChemistry,2016,vol.2016,p.3373-3379

[30]SyntheticCommunications,2016,vol.46,p.1741-1746

[31]Patent:WO2016/177746,2016,A1.Locationinpatent:Page/Pagecolumn25

[32]Patent:JP6145989,2017,B2.Locationinpatent:Paragraph0156

[33]Patent:KR2018/61825,2018,A.Locationinpatent:Paragraph0170-0173

[34]AdvancedSynthesisandCatalysis,2019,vol.361,p.1559-1563

[35]ChemicalCommunications,2019,vol.55,p.4230-4233

[36]OrganicLetters,2019

[37]OrganicLetters,2019,vol.21,p.4402-4406

[38]AdvancedSynthesisandCatalysis,2019,vol.361,p.3210-3216

[39]TetrahedronLetters,2020,vol.61

504-29-0

99-90-1

34658-66-7

[1]RSCAdvances,2015,vol.5,p.50178-50185

[2]GreenChemistry,2019,vol.21,p.1619-1624

[3]Molecules,2012,vol.17,p.13368-13375

[4]Patent:EP1582516,2005,A1.Locationinpatent:Page/Pagecolumn82

[5]RSCAdvances,2014,vol.4,p.27301-27307

[6]AdvancedSynthesisandCatalysis,2013,vol.355,p.2217-2221

[7]JournaloftheChineseChemicalSociety,2004,vol.51,p.1377-1380

[8]MonatsheftefurChemie,2018,vol.149,p.1835-1840

[9]SyntheticCommunications,2018,vol.48,p.1076-1084

[10]RSCAdvances,2013,vol.3,p.18923-18930

[11]TetrahedronLetters,2019,vol.60

[12]OrganicLetters,2014,vol.16,p.6212-6215

[13]TetrahedronLetters,2019,vol.60,p.739-742

[14]AdvancedSynthesisandCatalysis,2019,vol.361,p.2094-2106

[15]JournalofOrganicChemistry,2019,vol.84,p.6928-6939

597554-03-5

34658-66-7

2-4-(10-naphthalen-2-yl-anthracen-9-yl)-phenyl-imidazo1,2-apyridine

[1]Patent:EP1582516,2005,A1.Locationinpatent:Page/Pagecolumn82

[2]Patent:US2012/267615,2012,A1.Locationinpatent:Page/Pagecolumn51

[3]Patent:JP6145989,2017,B2.Locationinpatent:Paragraph0157

929899-20-7

34658-66-7

5-(4-imidazo1,2-apyridin-2-yl-phenyl)-2-methyl-2H-pyrazole-3-carboxylicacidmethylester

[1]CurrentPatentAssignee:PFIZERINC-WO2007/34278,2007,A2Locationinpatent:Page/Pagecolumn37

34658-66-7

138023-18-4

[1]HeterocyclicCommunications,2008,vol.14,p.27-32

[2]TetrahedronLetters,2019,vol.60,p.989-993

[3]ChineseJournalofChemistry,2019,vol.37,p.611-615

[4]SyntheticCommunications,2020,vol.50,p.197-206

Literature fold

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

34658-66-7 | 2-(4-Bromophenyl)imidazo[1,2-a]pyridine